ArticlePeerJ2020

Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study.

Hui-Ching Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.